Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2015 Apr;21(2):241-6.
doi: 10.1007/s12253-014-9814-6. Epub 2014 Jul 3.

Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer

Affiliations
Free article
Comparative Study

Prolactin and prolactin receptor expression in cervical intraepithelial neoplasia and cancer

Rafael Ascencio-Cedillo et al. Pathol Oncol Res. 2015 Apr.
Free article

Abstract

Prolactin receptor (PRLR) overexpression could play a role in tumorigenesis. The aim of this study was to determine prolactin (PRL) and PRLR expression in biopsies from patients with precursor lesions and uterine cervical cancer. PRLR expression was analyzed in 63 paraffin-embedded biopsies of uterine cervical tissue. In total, eleven low-grade squamous intraepithelial lesions (LSIL), 23 high-grade squamous intraepithelial lesions (HSIL), 21 uterine cervical cancers (UCC) and 8 normal epithelium (NE) were examined using immunoperoxidase staining and Western blot analysis. Additionally, PRL expression was identified in human cervical cancer serum and tissues. The PRLR expression was found to be significantly increased in cervical cancer in comparison with normal tissue and precursor lesions (P < 0.0003). The presence of the long isoform of the PRLR was observed only in cervical cancer tissues. Serum PRL levels were normal in all samples and local prolactin expression was similar in precursor lesions and cervical cancer by Western blot analysis. Our data suggest a possible role for PRLR in the progression of cervical cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Pathol. 1999 Mar;154(3):863-70 - PubMed
    1. J Obstet Gynaecol. 1998 May;18(3):260-2 - PubMed
    1. Proc Natl Acad Sci U S A. 1992 Aug 15;89(16):7713-6 - PubMed
    1. Gynecol Oncol. 1987 Mar;26(3):314-8 - PubMed
    1. Biochim Biophys Acta. 1996 Oct 9;1288(2):F55-78 - PubMed

Publication types

MeSH terms